Online citations, reference lists, and bibliographies.
← Back to Search

Intravoxel Incoherent Motion (IVIM) Histogram Biomarkers For Prediction Of Neoadjuvant Treatment Response In Breast Cancer Patients

G. Cho, L. Gennaro, E. Sutton, E. Zabor, Z. Zhang, D. Giri, L. Moy, D. Sodickson, E. Morris, E. Sigmund, S. Thakur
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Highlights • Intravoxel incoherent motion may predict response to breast neoadjuvant treatment.• Histogram analysis amplifies IVIM by quantifying spatial heterogeneity.• Pseudodiffusvity (Dp) showed the highest potential for response prediction.
This paper references
G
G. Belli (2016)
N
R. Panek (2015)
10.1007/s00330-013-2850-x
Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer
R. Richard (2013)
10.1148/RADIOLOGY.168.2.3393671
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.
D. Le Bihan (1988)
De fi nition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
M. Untch G. von Minckwitz
K
N. P. Jerome (2017)
10.1007/s00330-016-4630-x
Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations
R. Bedair (2016)
10.1002/nbm.1793
Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model
S. Kim (2012)
10.1245/s10434-011-2108-2
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
M. Kaufmann (2011)
10.1007/s13244-013-0219-y
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review
M. Lobbes (2013)
10.1118/1.4927255
Evaluation of diffusion models in breast cancer.
R. Panek (2015)
Italian Association of Physics in Medicine Working Group on , Quality assurance multicenter comparison of di ff erent MR scanners for quantitative di ff usionweighted imaging
D. J. Collins (2016)
10.1148/radiol.2016150702
Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.
S. Nougaret (2016)
Intravoxel incoherent motion di ff usionweighted MR imaging of breast cancer at 3 . 0 tesla : comparison of di ff erent curvefi tting methods
D. D. Giri (2015)
Evaluation of di ff usion models in breast cancer
M. Borri R. Panek (2015)
10.1016/j.mri.2016.10.005
Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Dejing Ma (2017)
10.1371/journal.pone.0122151
Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
C. Galbán (2015)
10.1177/146642407409400210
(b)
Miss A.O. Penney (1974)
10.1007/s00330-016-4241-6
Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging
C. Liu (2016)
10.1177/001452469000101110
"J."
G.G. Stokes (1890)
10.1002/jmri.24956
Quality assurance multicenter comparison of different MR scanners for quantitative diffusion‐weighted imaging
G. Belli (2016)
Italian Association of Physics in Medicine Working Group on, Quality assurance multicenter comparison of different MR scanners for quantitative diffusion-weighted imaging
G Belli (2016)
10.1097/MD.0000000000002420
Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
S. Che (2016)
Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrastenhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions
D. Ma (2017)
Di ff usion - weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer
I. Thomassin R. Richard
10.1002/jmri.24799
Intravoxel incoherent motion diffusion‐weighted MR imaging of breast cancer at 3.0 tesla: Comparison of different curve‐fitting methods
S. Suo (2015)
10.1002/jmri.25086
Semi‐automated quantitative intravoxel incoherent motion analysis and its implementation in breast diffusion‐weighted imaging
H. Dijkstra (2016)
10.1002/jmri.25514
Intravoxel incoherent motion (IVIM)‐derived parameters in diffusion‐weighted MRI: Associations with prognostic factors in invasive ductal carcinoma
Y. J. Lee (2017)
10.1097/RLI.0000000000000094
Quantitative Non-Gaussian Diffusion and Intravoxel Incoherent Motion Magnetic Resonance Imaging: Differentiation of Malignant and Benign Breast Lesions
M. Iima (2015)
G
M. Kaufmann (2012)
10.1016/j.ejca.2008.10.026
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E. Eisenhauer (2009)
10.1007/s00330-016-4318-2
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohort
N. Jerome (2016)
10.1200/JCO.2011.38.8595
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
G. von Minckwitz (2012)
10.1007/s00330-015-4087-3
Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors
G. Cho (2015)
10.1016/S1470-2045(13)70584-9
Neoadjuvant chemotherapy for breast cancer: any progress?
M. Colleoni (2014)
Intravoxel incoherent motion di ff usion - weighted MR imaging of breast cancer at 3 . 0 tesla : comparison of di ff erent curve - fi tting methods
N. Lin (2015)
10.1002/nbm.1245
Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
U. Sharma (2009)
10.1016/j.clbc.2015.02.002
Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
E. Bufi (2015)
10.1016/S0140-6736(13)62422-8
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
P. Cortázar (2014)
Di ff usionweighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer
C. P. Fulcheri (2013)
10.1007/s12032-011-9842-y
DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
Xi-ru Li (2011)
10.1159/000447765
Contribution of IVIM to Conventional Dynamic Contrast-Enhanced and Diffusion-Weighted MRI in Differentiating Benign from Malignant Breast Masses
Q. Wang (2016)
10.1002/mrm.22740
Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer
E. Sigmund (2011)
10.1515/9783111548050-027
P ? ? ? ? ? ? ? % ? ? ? ?
Lesterol IN Pregnancy (1991)
10.1093/ANNONC/MDS324
Neoadjuvant treatment of breast cancer.
A. Thompson (2012)
Moulder-Thompson, Neoadjuvant treatment of breast cancer
A M Thompson (2012)
10.1002/jmri.24462
Intravoxel incoherent motion diffusion‐weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma
L. Bokacheva (2014)
Intravoxel incoherent motion di ff usionweighted MR imaging of breast cancer at 3 . 0 tesla : comparison of di ff erent curvefi tting methods
D. D. Giri (2015)



This paper is referenced by
10.3892/ol.2018.9312
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification
M. Zhao (2018)
10.3389/fphys.2019.00708
Monitoring the Early Antiproliferative Effect of the Analgesic–Antitumor Peptide, BmK AGAP on Breast Cancer Using Intravoxel Incoherent Motion With a Reduced Distribution of Four b-Values
Natacha Raissa Doudou (2019)
10.1002/jmri.26293
Diffusion MRI of cancer: From low to high b‐values
Lei Tang (2019)
10.1016/j.crad.2017.10.021
Clinical role of breast MRI now and going forward.
D. Leithner (2018)
Application value of MRI apparent diffusion coefficient (ADC) before and after radical mastectomy for patients with breast cancer
L. Chen (2019)
10.1007/s00234-020-02630-6
Intravoxel incoherent motion as a tool to detect early microstructural changes in meningiomas treated with proton therapy
A. Franconeri (2021)
10.18383/j.tom.2019.00028
Discrimination of Malignant and Benign Breast Lesions Using Quantitative Multiparametric MRI: A Preliminary Study
Kurt Li (2020)
10.1016/j.ejro.2018.07.001
Breast biopsy navigation system with an assisted needle holder tool and 2D graphical user interface
J. Suthakorn (2018)
10.1002/jmri.27145
Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer
B. Reig (2020)
10.1002/jmri.26908
Diffusion MRI of the breast: Current status and future directions
M. Iima (2019)
10.1016/j.mri.2017.12.018
Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
Yunju Kim (2018)
10.2463/mrms.rev.2019-0124
Perfusion-driven Intravoxel Incoherent Motion (IVIM) MRI in Oncology: Applications, Challenges, and Future Trends.
M. Iima (2020)
Improved unsupervised physics-informed deep learning for intravoxel-incoherent motion modeling and evaluation in pancreatic cancer patients
Misha P.T. Kaandorp (2020)
10.1177/0284185120931689
Intravoxel incoherent motion MRI in evaluating inflammatory activity in ulcerative colitis: a pilot study.
Joanna Podgórska (2020)
10.18632/oncotarget.23195
Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis
W. Chu (2018)
10.1148/RYCAN.2019190008
q-Space Imaging Yields a Higher Effect Gradient to Assess Cellularity than Conventional Diffusion-weighted Imaging Methods at 3.0 T : A Pilot Study with Freshly Excised Whole-Breast Tumors
N. Senn (2019)
10.1007/s42058-020-00046-y
The role of magnetic resonance imaging on evaluating response of neoadjuvant therapy for breast cancer
Liang-cun Guo (2020)
10.1016/j.ejrad.2020.109093
Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer.
Mei-rong Zhao (2020)
10.3389/fmed.2020.00175
Current and Emerging Magnetic Resonance-Based Techniques for Breast Cancer
Apekshya Chhetri (2020)
Differential diagnosis and clinicopathological study of single index IVIM, DWI, and DKI models in benign and malignant breast lesions
Huiyang Wang (2020)
Semantic Scholar Logo Some data provided by SemanticScholar